KMT2A and leukemia: Brown et al. [29] used high-precision mass spectrometry to indicate that high levels of phosphorylated MEF2C S222 are obviously associated with chemotherapeutic resistance observed in a cytogenetic normal and MLL-recombinant leukemia cohort.